![Antibodies | Free Full-Text | Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody Antibodies | Free Full-Text | Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody](https://pub.mdpi-res.com/antibodies/antibodies-12-00047/article_deploy/html/images/antibodies-12-00047-g001-550.jpg?1689231500)
Antibodies | Free Full-Text | Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
![In Pediatric Lymphoblastic Leukemia of B-Cell Origin, a Small Population of Primitive Blast Cells Is Noncycling, Suggesting Them to be Leukemia Stem Cell Candidates | Pediatric Research In Pediatric Lymphoblastic Leukemia of B-Cell Origin, a Small Population of Primitive Blast Cells Is Noncycling, Suggesting Them to be Leukemia Stem Cell Candidates | Pediatric Research](https://media.springernature.com/full/springer-static/image/art%3A10.1203%2FPDR.0b013e3182092716/MediaObjects/41390_2011_Article_BFpr9201138_Fig1_HTML.jpg)
In Pediatric Lymphoblastic Leukemia of B-Cell Origin, a Small Population of Primitive Blast Cells Is Noncycling, Suggesting Them to be Leukemia Stem Cell Candidates | Pediatric Research
![The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation - The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation -](https://www.astctjournal.org/cms/asset/cb3c725c-9b1c-4e2c-9c07-ddc0801a1c28/gr1.jpg)
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation -
![IJMS | Free Full-Text | Cord Blood T Cells Expressing High and Low PKCζ Levels Develop into Cells with a Propensity to Display Th1 and Th9 Cytokine Profiles, Respectively IJMS | Free Full-Text | Cord Blood T Cells Expressing High and Low PKCζ Levels Develop into Cells with a Propensity to Display Th1 and Th9 Cytokine Profiles, Respectively](https://www.mdpi.com/ijms/ijms-22-04907/article_deploy/html/images/ijms-22-04907-g001.png)
IJMS | Free Full-Text | Cord Blood T Cells Expressing High and Low PKCζ Levels Develop into Cells with a Propensity to Display Th1 and Th9 Cytokine Profiles, Respectively
Semiconductor Nanoplatelets: A New Class of Ultrabright Fluorescent Probes for Cytometric and Imaging Applications | ACS Applied Materials & Interfaces
![Cells | Free Full-Text | Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance Cells | Free Full-Text | Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance](https://pub.mdpi-res.com/cells/cells-11-00410/article_deploy/html/images/cells-11-00410-g001.png?1643172030)
Cells | Free Full-Text | Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance
![Frontiers | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer Frontiers | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer](https://www.frontiersin.org/files/Articles/1213161/fimmu-14-1213161-HTML/image_m/fimmu-14-1213161-g001.jpg)
Frontiers | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer
![Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-023-02010-y/MediaObjects/41375_2023_2010_Fig1_HTML.png)
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia
![Targeting Prostate Cancer Using Bispecific T-Cell Engagers against Prostate-Specific Membrane Antigen | ACS Pharmacology & Translational Science Targeting Prostate Cancer Using Bispecific T-Cell Engagers against Prostate-Specific Membrane Antigen | ACS Pharmacology & Translational Science](https://pubs.acs.org/cms/10.1021/acsptsci.3c00159/asset/images/large/pt3c00159_0006.jpeg)
Targeting Prostate Cancer Using Bispecific T-Cell Engagers against Prostate-Specific Membrane Antigen | ACS Pharmacology & Translational Science
![Frontiers | A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice Frontiers | A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice](https://www.frontiersin.org/files/MyHome%20Article%20Library/1201853/1201853_Thumb_400.jpg)
Frontiers | A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice
![Cancers | Free Full-Text | PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients Cancers | Free Full-Text | PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients](https://www.mdpi.com/cancers/cancers-15-01389/article_deploy/html/images/cancers-15-01389-g001.png)
Cancers | Free Full-Text | PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
![Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnm.4444/MediaObjects/41591_2017_Article_BFnm4444_Fig1_HTML.jpg)
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine
![IJMS | Free Full-Text | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy IJMS | Free Full-Text | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy](https://pub.mdpi-res.com/ijms/ijms-23-05686/article_deploy/html/images/ijms-23-05686-g001.png?1653041029)
IJMS | Free Full-Text | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
![Cancers | Free Full-Text | The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity Cancers | Free Full-Text | The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity](https://www.mdpi.com/cancers/cancers-14-00299/article_deploy/html/images/cancers-14-00299-g001.png)
Cancers | Free Full-Text | The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
![IJMS | Free Full-Text | Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR” IJMS | Free Full-Text | Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”](https://www.mdpi.com/ijms/ijms-23-14563/article_deploy/html/images/ijms-23-14563-g001.png)
IJMS | Free Full-Text | Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
![Frontiers | Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma Frontiers | Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma](https://www.frontiersin.org/files/Articles/1110529/fmed-10-1110529-HTML/image_m/fmed-10-1110529-g001.jpg)
Frontiers | Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
![Cells | Free Full-Text | Double Positive CD4+CD8+ (DP) T-Cells Display Distinct Exhaustion Phenotype in Chronic Hepatitis C Cells | Free Full-Text | Double Positive CD4+CD8+ (DP) T-Cells Display Distinct Exhaustion Phenotype in Chronic Hepatitis C](https://www.mdpi.com/cells/cells-12-01446/article_deploy/html/images/cells-12-01446-g001.png)
Cells | Free Full-Text | Double Positive CD4+CD8+ (DP) T-Cells Display Distinct Exhaustion Phenotype in Chronic Hepatitis C
![Biomedicines | Free Full-Text | Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage Biomedicines | Free Full-Text | Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage](https://www.mdpi.com/biomedicines/biomedicines-10-01221/article_deploy/html/images/biomedicines-10-01221-g001.png)